- The pharmaceuticals company, Bristol-Myers Squibb, has put its estimated $100 million (£60 million) US consumer prescription drug media business up for review.
- The pharmaceuticals company, Bristol-Myers Squibb, has put its estimated $100 million (£60 million) US consumer prescription drug media business up for review.
The account is currently handle by Western International Media, California. The business includes the Pravachol cholesterol-reduction brand, which makes up the bulk of the spending, but also includes Buspar anxiety and Zerit HIV treatments.
Join a growing community of media, marketing and advertising professionals today
Read exclusive registrant only articles
Read more articles each month
Sign up for free specialised news bulletins
Register NowGet unprecedented new-business intelligence with access to ±±¾©Èü³µpk10’s new Market Reports.
Find out moreGet unlimited access to ±±¾©Èü³µpk10’s premium content for your whole company with a corporate licence.
Upgrade accessGet the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.
Create an alert now
.jpg)
.jpg)